Dosidal · Switzerland

Sequase XR, Retardtabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:63255 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 63255
atc: N05AH04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2013-10-01
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: N05AH04
authorisation_number: 63255
form: RETT
holder: Cheplapharm Schweiz GmbH
holder_partner_nr: 1106945
it_number: 01.05.0.
name: Sequase XR, Retardtabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
EApkdwOMFIeeKAXkLMdstEtoPapLpjs8KnAfC8ntMyRtf7KTTxxv5-ncMPPNOimQGIVjYnjGDj0UH_AyM3WAyQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:63255 · Related records in other markets · Dosidal